|
US2957906A
(en)
|
1955-10-25 |
1960-10-25 |
Monsanto Chemicals |
Ketones
|
|
US3227473A
(en)
|
1963-12-12 |
1966-01-04 |
Julian S Halbern |
Check identification
|
|
JPS5752354B2
(https=)
|
1973-10-22 |
1982-11-06 |
|
|
|
JPS5069091U
(https=)
|
1973-10-25 |
1975-06-19 |
|
|
|
US3980674A
(en)
|
1974-01-28 |
1976-09-14 |
Delmar Chemicals Limited |
2,3-Disubstituted 7-oxabicyclo-[2.2.1]-5-heptene
|
|
JPS5132733A
(en)
|
1974-09-10 |
1976-03-19 |
Kyowa Hakko Kogyo Kk |
Josozai |
|
US3954913A
(en)
|
1975-01-06 |
1976-05-04 |
The Standard Oil Company |
Stabilized nitrile polymers
|
|
JPS5188631U
(https=)
|
1975-01-10 |
1976-07-15 |
|
|
|
JPS5188631A
(en)
|
1975-01-31 |
1976-08-03 |
|
Hiiryoyosatsukinzai oyobi sonoseizoho
|
|
US4143054A
(en)
|
1977-11-04 |
1979-03-06 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane- and 7-oxabicycloheptene compounds
|
|
US4218478A
(en)
|
1979-01-05 |
1980-08-19 |
Ruiko Oiwa |
Trichostatin as an antiprotozoal agent
|
|
US4760067A
(en)
|
1979-08-15 |
1988-07-26 |
Merck & Co., Inc. |
Allylsulfoxide enzyme inhibitors
|
|
US4298752A
(en)
|
1980-09-19 |
1981-11-03 |
Regents Of The University Of California |
Cycloadduct precursors of cantharidin and method
|
|
US4614825A
(en)
|
1982-05-17 |
1986-09-30 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane and 7-oxabicycloheptene compounds
|
|
US4463015A
(en)
|
1982-08-18 |
1984-07-31 |
E. R. Squibb & Sons, Inc. |
Aryl substituted 7-oxabicycloheptane compounds, useful in inhibiting platelet aggregation
|
|
US4518696A
(en)
|
1983-01-11 |
1985-05-21 |
Chr. Hansen's Laboratory, Inc. |
Stabilized liquid bacterial suspension for oral administration to animals
|
|
US4524151A
(en)
|
1983-11-14 |
1985-06-18 |
E. R. Squibb & Sons, Inc. |
7-Oxabicycloheptane thio ethers useful as cardiovascular agents
|
|
JPS61176523A
(ja)
|
1985-01-30 |
1986-08-08 |
Teruhiko Beppu |
制癌剤
|
|
US4654355A
(en)
|
1985-08-01 |
1987-03-31 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane substituted amide-thioamide prostaglandin analogs
|
|
US4851553A
(en)
|
1986-06-04 |
1989-07-25 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane amido-carboxylic acids
|
|
US4816579A
(en)
|
1986-06-04 |
1989-03-28 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane amino-alcohol intermediates useful in making thromboxane A2 receptor antagonists
|
|
US4851423A
(en)
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
|
SU1553533A1
(ru)
|
1988-01-28 |
1990-03-30 |
Военная Краснознаменная академия химической защиты им.Маршала Советского Союза С.К.Тимошенко |
Способ получени 1,4-бисполифторалкил-7-оксбицикло [2.2.1]гептанов
|
|
JP2789365B2
(ja)
|
1988-12-14 |
1998-08-20 |
塩野義製薬株式会社 |
ジカルボン酸モノエステルおよびその製造法
|
|
RU2015980C1
(ru)
|
1990-02-06 |
1994-07-15 |
Е.Р.Сквибб энд Санз, Инк. |
7-оксабициклогептилзамещенные гетероциклические амиды или их стереоизомеры в качестве антагонистов рецепторов тромбоксана
|
|
US5763647A
(en)
|
1990-03-30 |
1998-06-09 |
Shionogi & Co., Ltd. |
Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives
|
|
FI925500A7
(fi)
|
1990-06-04 |
1992-12-03 |
Pfizer |
Aromaattisia pyrrolidiini- ja tiatsolidiiniamideja
|
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
|
US5266710A
(en)
|
1990-12-18 |
1993-11-30 |
Patel Ramesh N |
(Exo,exo)-7-oxabicyclo[2.2.1]heptane-2,3-dimethanol; monoacyl ester and diacyl ester
|
|
US5206386A
(en)
|
1991-03-20 |
1993-04-27 |
Isp Investments Inc. |
Controlled release N-substituted pyrrolidone esters and process for the use thereof
|
|
US5580858A
(en)
|
1991-06-10 |
1996-12-03 |
Alberta Research Council |
Immunosuppressive and tolerogenic modified Lewisx compounds
|
|
JP3134233B2
(ja)
|
1991-07-26 |
2001-02-13 |
株式会社林原生物化学研究所 |
α−グリコシル ケルセチンとその製造方法並びに用途
|
|
US5326898A
(en)
|
1992-02-11 |
1994-07-05 |
Allergan, Inc. |
Substituted phenylethenyl compounds having retinoid-like biological activity
|
|
US6602713B1
(en)
|
2001-02-09 |
2003-08-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
|
|
US5580856A
(en)
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
|
US5518993A
(en)
|
1994-08-12 |
1996-05-21 |
Buckman Laboratories International, Inc. |
Pesticidal compositions containing ethoxylated fatty amines for increasing the effectiveness of endothal and salts thereof
|
|
US5770382A
(en)
|
1994-12-30 |
1998-06-23 |
Ligand Pharmaceuticals, Inc. |
Tricyclic retinoids, methods for their production and use
|
|
US6222055B1
(en)
|
1995-07-06 |
2001-04-24 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angwandten Forschung E.V. |
Hydrolyzable and polymerizable and/or polyadditive silanes
|
|
DE19600707B4
(de)
|
1996-01-11 |
2004-02-19 |
Glüsenkamp, Karl-Heinz, Dr. |
Biyclische Anhydrid-Wirkstoff-Verbindungen, Verfahren zur Herstellung und Verwendung derselben
|
|
US5968965A
(en)
|
1996-01-30 |
1999-10-19 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US5925651A
(en)
|
1996-04-03 |
1999-07-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US6387673B1
(en)
|
1997-05-01 |
2002-05-14 |
The Salk Institute For Biological Studies |
Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
|
|
US6875451B2
(en)
|
1997-10-15 |
2005-04-05 |
Polarx Biopharmaceuticals Inc. |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
|
|
US6632823B1
(en)
|
1997-12-22 |
2003-10-14 |
Merck & Co., Inc. |
Substituted pyridine compounds useful as modulators of acetylcholine receptors
|
|
US6262116B1
(en)
|
1998-01-23 |
2001-07-17 |
Sloan-Kettering Institute For Cancer Research |
Transcription therapy for cancers
|
|
ATE413889T1
(de)
|
1998-06-05 |
2008-11-15 |
Nutrinia Ltd |
Insulin angereichertes säuglingsnährpräparat
|
|
AUPP466598A0
(en)
|
1998-07-14 |
1998-08-06 |
University Of Newcastle Research Associates Limited, The |
Product and process
|
|
US20040110822A1
(en)
|
1998-07-14 |
2004-06-10 |
The University Of Newcastle Research Associates |
Anhydride modified cantharidin analogues useful in the treatment of cancer
|
|
US6235755B1
(en)
|
1998-08-07 |
2001-05-22 |
Applied Research Systems Ars Holding N.A. |
FSH mimetics for the treatment of infertility
|
|
US20020151515A1
(en)
|
1999-06-18 |
2002-10-17 |
Roberts Bruce L. |
Preparation and use of superior vaccines
|
|
US6949624B1
(en)
|
1999-08-03 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cloning of the human nuclear receptor co-repressor gene
|
|
NZ517613A
(en)
|
1999-09-08 |
2004-01-30 |
Sloan Kettering Inst Cancer |
Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
|
|
US7605185B2
(en)
|
1999-11-23 |
2009-10-20 |
Gerhart Graupner |
Treatment of arrhythmia by retinoids affecting signal transduction
|
|
AU2001243253A1
(en)
|
2000-02-24 |
2001-09-03 |
Biocryst Pharmaceuticals, Inc. |
Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
|
|
JP4518627B2
(ja)
|
2000-03-14 |
2010-08-04 |
旭化成イーマテリアルズ株式会社 |
ヒドロキシポリアミド
|
|
WO2001070675A2
(en)
|
2000-03-24 |
2001-09-27 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
DE10038043B4
(de)
|
2000-08-02 |
2006-09-07 |
Walter, Michael, Dr. |
Phamakologisch wirksame Substanz zur Behandlung kardiovaskulärer Erkrankungen
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
US7199137B2
(en)
|
2000-09-21 |
2007-04-03 |
Smithkline Beecham Plc |
Imidazole derivatives as Raf kinase inhibitors
|
|
AU2001296558A1
(en)
|
2000-10-03 |
2002-04-15 |
Oncopharmaceutical, Inc. |
Inhibitors of angiogenesis and tumor growth for local and systemic administration
|
|
WO2002029018A2
(en)
|
2000-10-06 |
2002-04-11 |
Michigan State University |
Divinyl ether synthase gene and protein, and uses thereof
|
|
CN1213050C
(zh)
|
2000-11-23 |
2005-08-03 |
拜尔公司 |
氧杂双环[2.2.1]庚烷衍生物，其制备方法和作为农药的用途
|
|
US20020177692A1
(en)
|
2001-04-16 |
2002-11-28 |
Myriad Genetics, Incorporated |
BCL-XL-interacting protein and use thereof
|
|
WO2002066045A2
(en)
|
2001-02-16 |
2002-08-29 |
Genetics Institute, Llc. |
Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
|
|
AUPR392301A0
(en)
|
2001-03-23 |
2001-04-26 |
University Of Newcastle Research Associates Limited, The |
Protein phosphatase inhibitors
|
|
US20040253637A1
(en)
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
DE10122898A1
(de)
|
2001-05-11 |
2002-11-14 |
Haarmann & Reimer Gmbh |
Verwendung von Hydroxyflavanonen zur Maskierung des bitteren Geschmacks
|
|
US20070015144A9
(en)
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
|
AU2002322721B2
(en)
|
2001-08-03 |
2009-01-08 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents
|
|
US20040010045A1
(en)
|
2001-09-07 |
2004-01-15 |
Taolin Yi |
Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
|
|
US7179450B2
(en)
|
2001-09-20 |
2007-02-20 |
Medi-Physics, Inc. |
Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe
|
|
AU2002340253C1
(en)
|
2001-10-16 |
2011-03-31 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
ATE352319T1
(de)
|
2001-11-06 |
2007-02-15 |
Novartis Pharma Gmbh |
Kombination cyclooxygenase-2 inhibitor/ histone deacetylase inhibitor
|
|
EP1463713A1
(en)
|
2001-11-23 |
2004-10-06 |
Eli Lilly And Company |
Prodrugs of excitatory amino acids
|
|
JP2004035408A
(ja)
|
2002-02-15 |
2004-02-05 |
Chiron Corp |
テザシタビンを含有する安定な組成物
|
|
AU2003211576A1
(en)
|
2002-02-20 |
2003-09-09 |
Sueharu Horinouchi |
Histone deacetylase inhibitors and process for producing the same
|
|
US7148257B2
(en)
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
US7456219B2
(en)
|
2002-03-04 |
2008-11-25 |
Merck Hdac Research, Llc |
Polymorphs of suberoylanilide hydroxamic acid
|
|
EP1484972B1
(de)
|
2002-03-08 |
2008-11-19 |
Basf Se |
Fungizide mischungen auf der basis von prothioconazol mit einem insektizid
|
|
US6809118B2
(en)
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
|
IL149404A0
(en)
|
2002-04-29 |
2002-11-10 |
Yissum Res Dev Co |
METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
|
|
AU2003241346A1
(en)
|
2002-05-01 |
2003-11-17 |
The Cleveland Clinic Foundation |
Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
|
|
WO2003097835A2
(en)
|
2002-05-16 |
2003-11-27 |
Molecular Engines Laboratories |
Pharmaceutical compositions for the treatment of cancer
|
|
NZ538686A
(en)
|
2002-09-23 |
2008-01-31 |
Schering Corp |
Novel imidazopyrazines as cyclin dependent kinase inhibitors
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7189740B2
(en)
|
2002-10-15 |
2007-03-13 |
Celgene Corporation |
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
|
|
US8404716B2
(en)
|
2002-10-15 |
2013-03-26 |
Celgene Corporation |
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
|
|
AU2003291736A1
(en)
|
2002-11-05 |
2004-06-03 |
Cell Signaling Technology, Inc. |
Methods and materials for examining pathways associated with glioblastoma progression
|
|
GB0226855D0
(en)
|
2002-11-18 |
2002-12-24 |
Queen Mary & Westfield College |
Histone deacetylase inhibitors
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US20040197888A1
(en)
|
2002-12-31 |
2004-10-07 |
Armour Christopher D. |
Alternatively spliced isoforms of histone deacetylase 3 (HDAC3)
|
|
WO2004064727A2
(en)
|
2003-01-16 |
2004-08-05 |
Georgetown University |
Method of cancer treatment using hdac inhibitors
|
|
US8802116B2
(en)
|
2003-02-27 |
2014-08-12 |
Novasel Australia Pty. Ltd. |
Poloxamer emulsion preparations
|
|
US20050102708A1
(en)
|
2003-03-12 |
2005-05-12 |
Laurent Lecanu |
Animal model simulating neurologic disease
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
WO2005025620A2
(en)
|
2003-08-13 |
2005-03-24 |
Pharmacia Corporation |
Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
|
|
AU2004266233A1
(en)
|
2003-08-13 |
2005-03-03 |
Amgen, Inc. |
Melanin concentrating hormone receptor antagonist
|
|
US7378409B2
(en)
|
2003-08-21 |
2008-05-27 |
Bristol-Myers Squibb Company |
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
|
|
US20070135365A1
(en)
|
2003-08-21 |
2007-06-14 |
Katsuyuki Tanizawa |
Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiovascular disease caused thereby
|
|
US7094193B2
(en)
|
2003-08-28 |
2006-08-22 |
Philip Morris Usa Inc. |
High speed laser perforation of cigarette tipping paper
|
|
WO2005034866A2
(en)
|
2003-10-06 |
2005-04-21 |
Glaxo Group Limited |
Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
|
|
US20070208166A1
(en)
|
2003-10-24 |
2007-09-06 |
Exelixis, Inc. |
Tao Kinase Modulators And Method Of Use
|
|
JP2007511528A
(ja)
|
2003-11-13 |
2007-05-10 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
心肥大および心不全の処置としてのｔｒｐチャネル阻害方法
|
|
GB0328157D0
(en)
|
2003-12-04 |
2004-01-07 |
Imp College Innovations Ltd |
Compounds
|
|
EP1699436A2
(en)
|
2003-12-12 |
2006-09-13 |
Myogen, Inc. |
Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
|
|
US8652502B2
(en)
|
2003-12-19 |
2014-02-18 |
Cordis Corporation |
Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
|
|
US20050282893A1
(en)
|
2004-01-30 |
2005-12-22 |
Au Jessie L |
Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors
|
|
US20050283841A1
(en)
|
2004-02-02 |
2005-12-22 |
Mckinsey Timothy A |
Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure
|
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
FR2872704B1
(fr)
|
2004-07-12 |
2007-11-02 |
Laurent Schwartz |
Pluritherapie contre le cancer
|
|
CN1586500A
(zh)
|
2004-07-19 |
2005-03-02 |
俞锋 |
治疗肿瘤的斑蝥酸钠注射剂及其制备方法
|
|
CN101106997A
(zh)
|
2004-08-17 |
2008-01-16 |
约翰·霍普金斯大学 |
Pde5抑制剂组合物及治疗心脏病征候的方法
|
|
US7879569B2
(en)
|
2004-11-09 |
2011-02-01 |
The Trustees Of The University Of Pennsylvania |
Methods for diagnosis of myelodysplastic syndromes (MDS)
|
|
KR100677149B1
(ko)
|
2004-11-12 |
2007-02-02 |
삼성전자주식회사 |
잉크 조성물
|
|
US20060264415A1
(en)
|
2005-04-01 |
2006-11-23 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
CN1304396C
(zh)
|
2005-04-08 |
2007-03-14 |
中山大学 |
斑蝥素衍生物及其制备方法
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
GB0511266D0
(en)
|
2005-06-02 |
2005-07-13 |
Trust |
Chemical compounds
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
WO2007014029A2
(en)
|
2005-07-22 |
2007-02-01 |
The Regents Of The University Of Colorado, A Body Corporate |
Yin yang 1 as a treatment for cardiac hypertrophy and heart failure
|
|
JP2009504656A
(ja)
|
2005-08-10 |
2009-02-05 |
ノバルティス アクチエンゲゼルシャフト |
デアセチラーゼ阻害剤の使用法
|
|
EP2275095A3
(en)
|
2005-08-26 |
2011-08-17 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
US20070092553A1
(en)
|
2005-10-21 |
2007-04-26 |
Pfab Lp |
Compositions and methods of making rapidly dissolving lonically masked formulations
|
|
JP2009521424A
(ja)
|
2005-12-19 |
2009-06-04 |
メチルジーン インコーポレイテッド |
抗真菌剤の活性を増強するためのヒストンデアセチラーゼ阻害剤
|
|
CA2641308A1
(en)
|
2006-02-06 |
2007-08-16 |
Lixte Biotechnology Holdings, Inc. |
Use of phosphatases to treat tumors overexpressing n-cor
|
|
CN101466670B
(zh)
|
2006-04-07 |
2013-04-17 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
|
PE20080695A1
(es)
|
2006-04-27 |
2008-06-28 |
Banyu Pharma Co Ltd |
Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
|
|
US20090018142A9
(en)
|
2006-05-02 |
2009-01-15 |
Zhengping Zhuang |
Use of phosphatases to treat tumors overexpressing N-CoR
|
|
WO2008030617A2
(en)
|
2006-09-07 |
2008-03-13 |
Stemline Therapeutics, Inc. |
Cancer therapy with cantharidin and cantharidin analogs
|
|
JP2010502681A
(ja)
|
2006-09-08 |
2010-01-28 |
アンスティテュ・グスターブ・ルシ |
プロテインホスファターゼ１、ｇａｄｄ３４およびプロテインホスファターゼ１／ｇａｄｄ３４複合体の阻害剤、その調製および使用
|
|
US20080097561A1
(en)
|
2006-10-18 |
2008-04-24 |
Medcool, Inc. |
Dual cycle thermal system and method of use
|
|
WO2008058342A1
(en)
|
2006-11-15 |
2008-05-22 |
Genetic Technologies Limited |
Compounds, compositions and methods for controlling invertebrate pests
|
|
CA2676422C
(en)
|
2007-02-06 |
2018-10-16 |
Lixte Biotechnology Holdings, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
|
US8413445B2
(en)
|
2007-05-11 |
2013-04-09 |
General Electric Company |
Method and system for porous flame holder for hydrogen and syngas combustion
|
|
BR122017025062B8
(pt)
|
2007-06-18 |
2021-07-27 |
Merck Sharp & Dohme |
anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
|
|
US20090035292A1
(en)
|
2007-08-03 |
2009-02-05 |
Kovach John S |
Use of phosphatases to treat neuroblastomas and medulloblastomas
|
|
EA018618B1
(ru)
|
2007-10-01 |
2013-09-30 |
Ликсте Байотекнолоджи, Инк. |
Ингибиторы hdac
|
|
JP5069091B2
(ja)
|
2007-12-12 |
2012-11-07 |
三菱電機株式会社 |
監視カメラおよび監視カメラシステム
|
|
CN101970499B
(zh)
|
2008-02-11 |
2014-12-31 |
治疗科技公司 |
用于肿瘤治疗的单克隆抗体
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
CA2730148C
(en)
|
2008-08-01 |
2018-04-03 |
Lixte Biotechnology, Inc. |
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
|
|
EP2309853A4
(en)
|
2008-08-01 |
2012-04-25 |
Lixte Biotechnology Inc |
METHOD FOR CELL MITITULATING BY INHIBITION OF SERIN / THREONINE PHOSPHATASE
|
|
WO2010147612A1
(en)
|
2009-06-18 |
2010-12-23 |
Lixte Biotechnology, Inc. |
Methods of modulating cell regulation by inhibiting p53
|
|
US8227473B2
(en)
|
2008-08-01 |
2012-07-24 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
|
AU2009288730B2
(en)
|
2008-08-25 |
2013-06-20 |
Amplimmune, Inc. |
Compositions of PD-1 antagonists and methods of use
|
|
JP2012500855A
(ja)
|
2008-08-25 |
2012-01-12 |
アンプリミューン、インコーポレーテッド |
Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法
|
|
CN101367783A
(zh)
|
2008-10-10 |
2009-02-18 |
中国科学技术大学 |
5-羟甲基糠醛的制备方法
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
JP5844159B2
(ja)
|
2009-02-09 |
2016-01-13 |
ユニヴェルシテ デクス−マルセイユＵｎｉｖｅｒｓｉｔｅ Ｄ’Ａｉｘ−Ｍａｒｓｅｉｌｌｅ |
Ｐｄ−１抗体およびｐｄ−ｌ１抗体ならびにその使用
|
|
GB0903325D0
(en)
|
2009-02-26 |
2009-04-08 |
Univ Aberdeen |
Antibody molecules
|
|
US20120135522A1
(en)
|
2009-06-18 |
2012-05-31 |
Kovach John S |
Methods of modulating cell regulation by inhibiting p53
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
WO2011094683A2
(en)
|
2010-01-29 |
2011-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Method of identifying myelodysplastic syndromes
|
|
EP2560634A1
(en)
|
2010-04-23 |
2013-02-27 |
Piramal Enterprises Limited |
Nitric oxide releasing prodrugs of therapeutic agents
|
|
US20140235649A1
(en)
|
2011-05-24 |
2014-08-21 |
Lixte Biotechnology, Inc. |
Use of phosphatase inhibitors or histone deacetylase inhibitors to treat diseases characterized by loss of protein function
|
|
WO2013039854A1
(en)
|
2011-09-15 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
|
WO2013056211A2
(en)
|
2011-10-13 |
2013-04-18 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Telomerase reverse transcriptase deficience as diagnostic marker of myelodysplastic syndrome
|
|
WO2013180271A1
(ja)
|
2012-06-01 |
2013-12-05 |
大正製薬株式会社 |
含フッ素アミノ酸のプロドラッグ
|
|
CA2877167A1
(en)
|
2012-06-29 |
2014-01-03 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
|
|
JP6262225B2
(ja)
|
2012-06-29 |
2018-01-17 |
リクスト・バイオテクノロジー，インコーポレイテッド |
オキサビシクロヘプタン類、および再灌流障害の治療のためのオキサビシクロヘプタン類
|
|
US9738933B2
(en)
|
2012-12-05 |
2017-08-22 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS
|
|
WO2014137741A1
(en)
|
2013-03-05 |
2014-09-12 |
Lixte Biotechnology, Inc. |
Hdac inhibitors for treating traumatic brain injury
|
|
EP2968279A4
(en)
|
2013-03-15 |
2016-09-28 |
Lixte Biotechnology Inc |
SANGUINARIN ANALOG PPC2 HEMMER FOR CANCER TREATMENT
|
|
EP2983661B1
(en)
|
2013-04-09 |
2024-05-29 |
Lixte Biotechnology, Inc. |
Formulations of oxabicycloheptanes and oxabicycloheptenes
|
|
JP2016538281A
(ja)
|
2013-11-15 |
2016-12-08 |
リクスト・バイオテクノロジー，インコーポレイテッド |
血液脳関門を通過するタンパク質ホスファターゼ阻害剤
|
|
US9051332B1
(en)
|
2013-11-20 |
2015-06-09 |
Transitions Optical, Inc. |
Photochromic indeno-fused ring pyran compounds
|
|
PE20170255A1
(es)
|
2014-01-24 |
2017-03-22 |
Dana Farber Cancer Inst Inc |
Moleculas de anticuerpo que se unen a pd-1 y usos de las mismas
|
|
AU2015254949A1
(en)
|
2014-04-28 |
2016-10-06 |
Alembic Pharmaceuticals Limited |
Novel polymorphic forms of Vortioxetine and its pharmaceutically acceptable salts
|
|
WO2015196073A1
(en)
*
|
2014-06-20 |
2015-12-23 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes for the treatment of ovarian cancer
|
|
US10071094B2
(en)
|
2014-07-24 |
2018-09-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes
|
|
WO2016040877A1
(en)
|
2014-09-12 |
2016-03-17 |
Lixte Biotechnology, Inc. |
Human dosing of phosphatase inhibitor
|
|
WO2016061193A1
(en)
|
2014-10-15 |
2016-04-21 |
Lixte Biotechnology, Inc. |
Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid
|
|
AU2016219853B2
(en)
|
2015-02-19 |
2019-05-16 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
|
|
KR20250004095A
(ko)
|
2015-04-17 |
2025-01-07 |
브리스톨-마이어스 스큅 컴퍼니 |
항-pd-1 항체 및 또 다른 항체의 조합물을 포함하는 조성물
|
|
DK3294287T3
(da)
|
2015-05-15 |
2020-06-08 |
Lixte Biotechnology Inc |
Oxabicycloheptan-prodrugs
|
|
AU2016323985B2
(en)
|
2015-09-17 |
2022-12-15 |
Novartis Ag |
CAR T cell therapies with enhanced efficacy
|
|
EP3407887B1
(en)
|
2016-01-27 |
2021-09-01 |
Lixte Biotechnology, Inc. |
Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitor
|
|
WO2017176289A1
(en)
|
2016-04-08 |
2017-10-12 |
Celgene Corporation |
Uses of lenalidomide and car t-cells
|
|
MX2019006694A
(es)
|
2016-12-08 |
2019-08-21 |
Lixte Biotechnology Inc |
Oxabicicloheptanos para la modulacion de la respuesta inmunitaria.
|
|
US20210275521A1
(en)
|
2017-12-05 |
2021-09-09 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes for treatment of secondary acute myeloid leukemia
|
|
WO2019241536A1
(en)
|
2018-06-14 |
2019-12-19 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes for enhancing car t cell function
|
|
RU201598U1
(ru)
|
2020-05-14 |
2020-12-22 |
Андрей Владимирович Дмитриев |
Безреагентная испарительная градирня
|
|
EP4281063A4
(en)
|
2021-01-19 |
2024-11-13 |
Lixte Biotechnology, Inc. |
OXABICYCLOHEPTANE FOR THE TREATMENT OF SMALL CELL LUNG CANCER
|
|
TW202342039A
(zh)
|
2022-01-04 |
2023-11-01 |
美商利克斯特生物科技公司 |
用於治療癌症或預防、抑制或降低癌症轉移風險之組成物及方法
|